SYBX Insider Trading
Insider Ownership Percentage: 2.62%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $3,086.48
Synlogic Share Price & Price History
Current Price: $1.12
Price Change: ▼ Price Decrease of -0.02 (-1.75%)
As of 01/16/2026 05:00 PM ET
Synlogic Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 10/29/2025 | Mary Beth Dooley | Insider | Sell | 157 | $1.81 | $284.17 | 12,744 |  |
| 2/3/2025 | Mary Beth Dooley | Insider | Sell | 2,107 | $1.33 | $2,802.31 | 13,045 | |
| 10/29/2024 | Mary Beth Dooley | Insider | Sell | 79 | $1.40 | $110.60 | 15,152 | |
| 4/2/2024 | Antoine Awad | COO | Sell | 372 | $1.73 | $643.56 | 33,859 | |
| 4/2/2024 | Mary Beth Dooley | Insider | Sell | 188 | $1.73 | $325.24 | 15,231 | |
| 4/3/2023 | Antoine Awad | COO | Sell | 429 | $8.70 | $3,732.30 | 4,982 | |
| 4/3/2023 | Aoife Brennan | Insider | Sell | 1,269 | $8.70 | $11,040.30 | 17,086 | |
| 4/3/2023 | Michael Vangsted Jensen | CFO | Sell | 170 | $8.70 | $1,479.00 | 3,129 | |
Synlogic Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 11/17/2025 | Citadel Advisors LLC | 29,011 | $49K | 0.0% | N/A | 0.248% |  |
| 2/13/2025 | Renaissance Technologies LLC | 22,310 | $31K | 0.0% | -69.0% | 0.191% | |
| 11/13/2024 | FMR LLC | 166,724 | $0.25M | 0.0% | -27.6% | 1.425% | |
| 8/9/2024 | Renaissance Technologies LLC | 100,530 | $0.15M | 0.0% | -15.1% | 0.859% | |
| 2/13/2024 | Armistice Capital LLC | 1,055,000 | $4.06M | 0.1% | +75.9% | 11.480% | |
| 1/8/2024 | Harbor Capital Advisors Inc. | 30,685 | $0.12M | 0.0% | +43.4% | 0.334% | |
| 11/15/2023 | Armistice Capital LLC | 599,874 | $1.69M | 0.0% | N/A | 13.098% | |
| 11/13/2023 | WINTON GROUP Ltd | 12,401 | $35K | 0.0% | N/A | 0.271% | |
| 10/20/2023 | Harbor Capital Advisors Inc. | 21,403 | $60K | 0.0% | -92.6% | 0.467% | |
| 7/31/2023 | PVG Asset Management Corp | 68,455 | $29K | 0.1% | -31.7% | 0.100% | |
| 7/11/2023 | Harbor Capital Advisors Inc. | 290,605 | $0.13M | 0.0% | +10.1% | 0.426% | |
| 4/26/2023 | Harbor Capital Advisors Inc. | 264,026 | $0.17M | 0.0% | -15.3% | 0.387% | |
| 1/13/2023 | Flagship Harbor Advisors LLC | 40,000 | $30K | 0.0% | -28.6% | 0.057% | |
| 11/14/2022 | RA Capital Management L.P. | 4,618,415 | $4.39M | 0.1% | -20.7% | 6.576% | |
| 11/14/2022 | UBS Oconnor LLC | 465,741 | $0.44M | 0.0% | -14.2% | 0.663% | |
| 10/28/2022 | Harbor Capital Advisors Inc. | 318,309 | $0.30M | 0.3% | -10.0% | 0.453% | |
| 8/12/2022 | Ikarian Capital LLC | 474,360 | $0.55M | 0.1% | -8.7% | 0.675% | |
| 8/4/2022 | Royce & Associates LP | 434,041 | $0.50M | 0.0% | -10.3% | 0.618% | |
| 5/5/2022 | UMA Financial Services Inc. | 17,302 | $30K | 0.0% | N/A | 0.025% | |
| 4/28/2022 | Harbor Capital Advisors Inc. | 354,998 | $0.85M | 0.4% | -18.9% | 0.509% | |
| 2/15/2022 | Stonepine Capital Management LLC | 1,064,135 | $2.58M | 1.2% | +6.4% | 1.527% | |
| 2/14/2022 | Opaleye Management Inc. | 850,000 | $2.06M | 0.4% | N/A | 1.219% | |
| 2/14/2022 | LMR Partners LLP | 550,000 | $1.33M | 0.0% | +10.0% | 0.789% | |
| 2/10/2022 | Acadian Asset Management LLC | 77,655 | $0.19M | 0.0% | +796.3% | 0.111% | |
| 2/10/2022 | Connor Clark & Lunn Investment Management Ltd. | 32,161 | $78K | 0.0% | N/A | 0.046% | |
| 2/9/2022 | Dimensional Fund Advisors LP | 632,168 | $1.53M | 0.0% | -11.4% | 0.907% | |
| 2/4/2022 | Harbor Capital Advisors Inc. | 437,550 | $1.06M | 0.4% | N/A | 0.628% | |
| 11/16/2021 | Suvretta Capital Management LLC | 60,000 | $0.18M | 0.0% | N/A | 0.115% | |
| 11/16/2021 | Two Sigma Advisers LP | 402,900 | $1.23M | 0.0% | -41.4% | 0.769% | |
| 11/16/2021 | Two Sigma Investments LP | 447,650 | $1.37M | 0.0% | -32.9% | 0.855% | |
| 11/16/2021 | Laurion Capital Management LP | 80,100 | $0.24M | 0.0% | N/A | 0.153% | |
| 11/15/2021 | RA Capital Management L.P. | 6,666,666 | $20.33M | 0.3% | N/A | 12.729% | |
| 11/15/2021 | Caas Capital Management LP | 50,000 | $0.15M | 0.0% | N/A | 0.095% | |
| 11/15/2021 | Dimensional Fund Advisors LP | 713,889 | $2.18M | 0.0% | -25.1% | 1.363% | |
| 11/15/2021 | Franklin Resources Inc. | 101,700 | $0.31M | 0.0% | N/A | 0.194% | |
| 11/12/2021 | Renaissance Technologies LLC | 188,672 | $0.58M | 0.0% | -28.6% | 0.360% | |
| 11/12/2021 | Stonepine Capital Management LLC | 1,000,000 | $3.05M | 1.4% | N/A | 1.909% | |
| 11/12/2021 | Magnetar Financial LLC | 32,881 | $100K | 0.0% | N/A | 0.063% | |
| 11/9/2021 | BlackRock Inc. | 372,959 | $1.14M | 0.0% | +1.6% | 0.712% | |
| 11/2/2021 | Raymond James & Associates | 11,000 | $34K | 0.0% | N/A | 0.021% | |
Data available starting January 2016
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States. Its pipeline include SYNB1618, an orally administered, non-systemically absorbed drug candidate to treat phenylketonuria; SYNB1934, an orally administered, non-systemically absorbed drug candidate, which is in Phase III clinical trial to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate, which is in Phase I clinical to treat homocystinuria; SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase II clinical trial for the treatment of enteric hyperoxaluria; and SYNB2081 to lower uric acid for the potential treatment of gout. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. for the research and pre-clinical development of a synthetic biotic medicine for the treatment of inflammatory bowel disease; and Ginkgo Bioworks, Inc. Synlogic, Inc. is based in Cambridge, Massachusetts.
Read More on Synlogic
Volume
5,246 shs
Average Volume
18,836 shs
Market Capitalization
$13.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.39
Who are the company insiders with the largest holdings of Synlogic?
